{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:31:43Z","timestamp":1761845503349,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.tranon.2022.101369","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T06:56:39Z","timestamp":1644994599000},"page":"101369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9931-1866","authenticated-orcid":false,"given":"Takumi","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuki","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Toriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2320-7958","authenticated-orcid":false,"given":"Takeyuki","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2022.101369_bib0001","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2215\/CJN.08070715","article-title":"Long-term renal outcomes after cisplatin treatment","volume":"11","author":"Latcha","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tranon.2022.101369_bib0002","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C","article-title":"Improvement of cis- dichlorodiammine platinum (NSC 119875): therapeutic index in an animal model","volume":"39","author":"Cvitkovic","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.tranon.2022.101369_bib0003","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjc.6600884","article-title":"Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients","volume":"88","author":"de Jongh","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tranon.2022.101369_bib0004","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/jjco\/hyt122","article-title":"Short hydration in chemotherapy containing cisplatin (\u226575 mg\/m2) for patients with lung cancer: a prospective study","volume":"43","author":"Horinouchi","year":"2013","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2022.101369_bib0005","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.tranon.2022.101369_bib0006","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.semnephrol.2010.09.005","article-title":"Nephrotoxicity from chemo-therapeutic agents: clinical manifestations, pathobiology, and prevention\/therapy","volume":"30","author":"Perazella","year":"2010","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.tranon.2022.101369_bib0007","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","article-title":"Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update","volume":"86","author":"dos Santos","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tranon.2022.101369_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.ndt.a091984","article-title":"Role of vascular congestion in cisplatin-induced acute renal failure in the rat","volume":"7","author":"Luke","year":"1992","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tranon.2022.101369_bib0009","first-page":"253","article-title":"Cisplatin-induced nephrotoxicity causes altered renal hemodynamics in Wistar Kyoto and spontaneously hypertensive rats: role of augmented renal alpha-adrenergic responsiveness","volume":"59","author":"Hye","year":"2017","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tranon.2022.101369_bib0010","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2215\/CJN.05271107","article-title":"Preoperative use of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery","volume":"3","author":"Arora","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tranon.2022.101369_bib0011","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.2215\/CJN.05480610","article-title":"Predictors of acute kidney injury in septic shock patients: an observational cohort study","volume":"6","author":"Plataki","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tranon.2022.101369_bib0012","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3349\/ymj.2013.54.4.965","article-title":"Acute kidney injury in patients with sepsis and septic shock: risk factors and clinical outcomes","volume":"54","author":"Suh","year":"2013","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.tranon.2022.101369_bib0013","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1159\/000210574","article-title":"Effects of losartan pretreatment in an experimental model of ischemic acute kidney injury","volume":"112","author":"Molinas","year":"2009","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.tranon.2022.101369_bib0014","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jamainternmed.2018.4749","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with outcomes after acute kidney injury","volume":"178","author":"Brar","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.tranon.2022.101369_bib0015","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1248\/bpb.b20-00174","article-title":"Telmisartan exacerbates cisplatin-induced nephrotoxicity in a mouse model","volume":"43","author":"Hosoda","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.tranon.2022.101369_bib0016","article-title":"Preventive effect of edaravone ointment on cyclophosphamide-chemotherapy induced alopecia","author":"Yoneda","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.tranon.2022.101369_bib0017","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1152\/ajprenal.00512.2015","article-title":"Repeated administration of low-dose cisplatin in mice induces fibrosis","volume":"310","author":"Sharp","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.tranon.2022.101369_bib0018","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.4049\/jimmunol.1700717","article-title":"Interaction of neutrophils with macrophages promotes IL-1\u03b2 maturation and contributes to hepatic ischemia\u2013reperfusion injury","volume":"199","author":"Sadatomo","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.tranon.2022.101369_bib0019","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yjmcc.2019.04.025","article-title":"Cardiac arrhythmias after renal I\/R depend on IL-1\u03b2","volume":"131","author":"Alarcon","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.tranon.2022.101369_bib0020","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1124\/dmd.107.017459","article-title":"Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor","volume":"35","author":"Yamada","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tranon.2022.101369_bib0021","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1124\/dmd.105.008938","article-title":"Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans","volume":"34","author":"Yamashiro","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tranon.2022.101369_bib0022","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1124\/dmd.105.009175","article-title":"Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans","volume":"34","author":"Ishiguro","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tranon.2022.101369_bib0023","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1124\/jpet.106.103390","article-title":"Vectorial transport of enalapril by Oatp1a1\/Mrp2 and OATP1B1 and OATP1B3\/MRP2 in rat and human livers","volume":"318","author":"Liu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tranon.2022.101369_bib0024","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.clinthera.2011.04.018","article-title":"Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men","volume":"33","author":"Tian","year":"2011","journal-title":"Clin. Ther."},{"key":"10.1016\/j.tranon.2022.101369_bib0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMra064398","article-title":"Normotensive ischemic acute renal failure","volume":"357","author":"Abuelo","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2022.101369_bib0026","doi-asserted-by":"crossref","first-page":"12768","DOI":"10.1021\/ja053353c","article-title":"Cisplatin carbonato complexes. Implications for uptake, antitumor properties, and toxicity","volume":"127","author":"Centerwall","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tranon.2022.101369_bib0027","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1158\/1535-7163.MCT-12-0926","article-title":"Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics","volume":"12","author":"Cynthia","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tranon.2022.101369_bib0028","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41390-019-0288-9","article-title":"Angiotensin inhibition in the developing kidney; tubulointerstitial effect","volume":"85","author":"Yoo","year":"2019","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.tranon.2022.101369_bib0029","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1152\/ajprenal.00415.2009","article-title":"HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation","volume":"298","author":"Yadav","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.tranon.2022.101369_bib0030","first-page":"522","article-title":"Telmisartan counteracts TGF-\u03b21 induced epithelial\u2013to\u2013mesenchymal transition via PPAR-\u03b3 in human proximal tubule epithelial cells","volume":"5","author":"Chen","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.tranon.2022.101369_bib0031","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/HYPERTENSIONAHA.111.173542","article-title":"High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-\u03b3 target genes in patients with the metabolic syndrome","volume":"58","author":"B\u00e4hr","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.tranon.2022.101369_bib0032","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/infdis\/jiy064","article-title":"Telmisartan therapy does not improve lymph node or adipose tissue fibrosis more than continued antiretroviral therapy alone","volume":"217","author":"Utay","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tranon.2022.101369_bib0033","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/147323000002800401","article-title":"Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients","volume":"28","author":"Stangier","year":"2000","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.tranon.2022.101369_bib0034","article-title":"Human umbilical cord blood mononuclear cells protect against renal tubulointerstitial fibrosis in cisplatin-treated rats","volume":"121","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tranon.2022.101369_bib0035","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.3390\/ijms21114002","article-title":"Association of the epithelial-mesenchymal transition (EMT) with cisplatin resistance","volume":"21","author":"Ashrafizadeh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2022.101369_bib0036","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2019.12.024","article-title":"Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis","volume":"472","author":"Liu","year":"2020","journal-title":"Cancer Lett."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523322000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523322000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:21:47Z","timestamp":1761844907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523322000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":36,"alternative-id":["S1936523322000316"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2022.101369","relation":{},"ISSN":["1936-5233"],"issn-type":[{"type":"print","value":"1936-5233"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2022.101369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101369"}}